Join to View Full Profile
PO Box 431002Brooklyn Center, MN 55443
Dr. Briesacher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Briesacher is a pediatrician working in the health technology sector. He completed his medical education at the University of Missouri-Columbia School of Medicine in 1992 and his residency in pediatrics at University of Utah Health from 1992 to 1995. He has published research in various medical journals, including an upcoming article in the American Journal of Lifestyle Medicine. His work on glucose monitoring and invasive type III group B streptococci has been cited by other publications multiple times, indicating a contribution to these areas of research. His current work at Lore, a company applying new technology to established science to positively impact people's lives and health, focuses on how positive change in identity and behavior impacts the community standard of care across multiple medical conditions.
Education & Training
University of Utah HealthResidency, Pediatrics, 1992 - 1995
Central Methodist UniversityBS, Chemistry, Summa cum laude, 1988 - 1992
University of Missouri-Columbia School of MedicineClass of 1992
Certifications & Licensure
UT State Medical License 1993 - 2026
Publications & Presentations
PubMed
- 1 citationsMusculoskeletal Failure.Elizabeth A Joy, Mark Briesacher, Benjamin Wiegand
American Journal of Lifestyle Medicine. 2024-05-24 - 18 citationsDemonstrating the Clinical Impact of Continuous Glucose Monitoring Within an Integrated Healthcare Delivery System.Brad Isaacson, Stephanie Kaufusi, Jeff Sorensen, Elizabeth Joy, Christopher M. Jones
Journal of Diabetes Science and Technology. 2020-09-16 - 63 citationsIdentification of a highly encapsulated, genetically related group of invasive type III group B streptococciShinji Takahashi, Elisabeth E. Adderson, Yukiko Nagano, Noriyuki Nagano, Mark R. Briesacher
The Journal of Infectious Diseases. 1998-04-01
Press Mentions
Will Federal Mandate Boost Utah’s COVID-19 Vaccinations? See What Health Experts Have to SayNovember 4th, 2021- Another Boise Hospital to Require Vaccination for EmploymentNovember 1st, 2021
- 21 GOP Attorneys General Pressure Biden to Halt Vaccination MandateOctober 28th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
